July 2013 FDA Recall Drug by Actavis Inc
D-855-2013 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Actavis Inc on July 31, 2013 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-855-2013

Reason for Recall
Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Initiated
07-31-2013
Reported
08-14-2013
Quantity
15,132 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Nationwide and Puerto Rico
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.

Batch or Lot Expiration Information

Lot# : CG2D18A, Exp 06/14